Dataset from US Population-Based Longitudinal Survey in Migraine: ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME)

The ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) (US) was conducted to understand the epidemiology and burden of migraine, identify barriers to the initiation of preventive and acute therapies in migraine, and understand how the introduction of new classes of migraine medications influences health care delivery and migraine care, as well as to understand perceptions/attitudes about people with migraine.

Additional Information
OVERCOME data may be used to characterize those who are/are not seeking care, diagnosed and treated with medications for migraine as well as to analyze the population disease state, the burden, impact, and functioning of people with migraine, and the beliefs, behaviors and outcomes of people with migraine. It may also be used to understand medication use among people with migraine at a single point and across time, to evaluate beliefs, behaviors, and outcomes with regard to medication class level, and to evaluate migraine attack-related characteristics. However, evaluating the efficacy or safety of any individual medication or comparing efficacy and safety between medications is out of scope for this dataset.

Publication
Richard B. Lipton MD, Robert A. Nicholson PhD, Michael L. Reed PhD, Andre B. Araujo PhD, Dena H. Jaffe PhD, Douglas E. Faries PhD, Dawn C. Buse PhD, Robert E. Shapiro MD, PhD, Sait Ashina MD, M. Janelle Cambron-Mellott PhD, John C. Rowland MS, Eric M. Pearlman MD, PhD. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

Headache.2022 Feb;62(2):122-140. doi: 10.1111/head.14259. Epub 2022 Jan 25.